The current cancer treatments in the face of a difficult is, how in the healing process is only for malignant cells and don't kill healthy cells. Scientists in Canada, a new study will likely help to solve this problem, a development deal with cancer cells can better without damaging the health of the cell therapy and the drugs. The relevant papers on January 4, published online natural-biological technology "(Nature Biotechnology).
Canada McMaster university researchers first demonstrates the normal human stem cells and the difference between the cancer stem cells. This discovery ultimately help development on an individual patient of cancer treatment, and will provide a drug development model, through the automatic screening to destroy the cancer cells have the potential for molecules. Zhengzhou university YiFuYuan ZhangMingZhi oncology
McMaster university stem cells and cancer research center science competent Mick Bhatia said: "normal stem cells and cancer stem cells, it is difficult to tell, now we have a way....... The discovery also let us can in the lab more normal stem cells and cancer stem cells, and according to the expression of genes and the response from the drug to define the difference between the two. The most important is, now, we can use the findings, find a or a series of can kill the cancer stem cells, and won't hurt normal drug healthy cells."
Bhatia said: "McMaster university has the best selection platform and chemistry lab, found to fighting infectious disease of molecular Eric Brown and professor Gerry Wright in here, they experience, now we can put all this focus on up. Research group goal is to eliminate cancer.
